These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance. Kruszynska YT; Olefsky JM; Frias JP Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639 [TBL] [Abstract][Full Text] [Related]
27. [Behavior of nonesterified fatty acids during the treatment of obesity with appetite depressants]. Hunecke I; Reuter W Z Gesamte Inn Med; 1971 Jan; 26(1):36-8. PubMed ID: 5560760 [No Abstract] [Full Text] [Related]
28. [Effect of parturition on serum glycerol and non-esterified fatty acids in obese and normal weight women]. Adoncecchi L; Marrocco W; Perrone G; Santoro A; Suraci C; Pecora P Boll Soc Ital Biol Sper; 1983 Jul; 59(7):977-82. PubMed ID: 6626336 [TBL] [Abstract][Full Text] [Related]
29. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes. Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758 [TBL] [Abstract][Full Text] [Related]
30. [Effect of dopamine and metaproterenol on serum free fatty acids with regard to the induction of cardiac arrhythmia]. Marquardt R Med Welt; 1979 May; 30(18):707-8. PubMed ID: 440064 [No Abstract] [Full Text] [Related]
31. Plasma unesterified fatty acid in normal, obese and diabetic Chinese. Kao JT; Ou CT Taiwan Yi Xue Hui Za Zhi; 1976 Mar; 75(03):198-204. PubMed ID: 1066437 [No Abstract] [Full Text] [Related]
32. L-dopa effects on renal function in obese subjects. Banasiak MF; Marshall WP; Kalkhoff RK N Engl J Med; 1977 May; 296(19):1122. PubMed ID: 850528 [No Abstract] [Full Text] [Related]
33. [Effect of lysine vasopressin on plasma free fatty acid level in obese women]. Pawlikowski M; Piontek W Endokrynol Pol; 1972; 23(2):95-9. PubMed ID: 5030358 [No Abstract] [Full Text] [Related]
34. [A study of the mobilization of free plasma fatty acids by noradrenaline in obese patients]. Hanoune J; Salmon D; Laudat P; de Gennes JL Ann Endocrinol (Paris); 1967; 28(6):798-806. PubMed ID: 5596129 [No Abstract] [Full Text] [Related]
35. [Amantadine potentiation of G.H. relase evoked by L-dopa and its inhibition by nonesterified fatty acids]. Cabezas-Cerrato J; Casanueva Freijo F; Villanueva Aranguren L; Avila C; Fernández-Cruz A Rev Clin Esp; 1977 May; 145(3):165-8. PubMed ID: 866739 [No Abstract] [Full Text] [Related]
36. [Free fatty acids and cholesterol plasma levels following oxytocin administration in women with hypothalamic syndrome and simple obesity]. Swierczek J; Wajdowicz A; Paradysz A Endokrynol Pol; 1975; 26(2):105-9. PubMed ID: 1132370 [No Abstract] [Full Text] [Related]
37. Changes of plasma free fatty acids levels after oxytocin administration in man. Yano S; Kotani S; Miyatake A; Yamamura Y Endocrinol Jpn; 1972 Apr; 19(2):191-5. PubMed ID: 4677721 [No Abstract] [Full Text] [Related]
38. Are plasma amino acid levels elevated in obesity? Felig P; Marliss E; Cahill GF N Engl J Med; 1970 Jan; 282(3):166. PubMed ID: 5409545 [No Abstract] [Full Text] [Related]
39. A biochemical view: plasma free fatty acids and risk of stroke in the cardiovascular health study. Sertoglu E; Kayadibi H; Uyanik M Int J Stroke; 2015 Apr; 10(3):E28. PubMed ID: 25777836 [No Abstract] [Full Text] [Related]
40. [Action of L-dopa and dopamine on plasma free fatty acids in normal and obese subjects]. Balestreri R; Barreca T; Marcenaro A; Valice S Boll Soc Ital Biol Sper; 1975 May; 51(9-10):614-20. PubMed ID: 1203133 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]